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ABSTRACT 
 
 We consider a realization of the XOR logic gate in a system involving two competing 
biocatalytic reactions, for which the logic-1 output is defined by these two processes causing a 
change in the optically detected signal. A model is developed for describing such systems in an 
approach suitable for evaluation of the analog noise amplification properties of the gate and 
optimization of its functioning. The initial data are fitted for gate quality evaluation within the 
developed model, and then modifications are proposed and experimentally realized for 
improving the gate functioning. 
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1. Introduction 
 
 Rapid development of chemical computing,1-7 i.e., information processing encoded in 
chemical reaction kinetics, in turn a subarea of unconventional computing,8,9 resulted in 
realizations of various chemical systems carrying out Boolean logic gates, such as AND,10,11 
OR,12 NAND,13,14 NOR,15-18 INHIB,19-22 XOR,23-26 etc. Recently emerging field of biochemical 
computing27-29 has resulted in systems for Boolean logic gate functions, as well as few-gate 
networks, utilizing biomolecular processes, such as those based on proteins/enzymes,30-38 
antigens/antibodies,39,40 DNAzymes,41,42 DNA,43,44 RNA45-49 and even whole biological cells.50 
One of the motivations for the interest in biocomputing systems has been their potential 
applications for novel multi-signal responsive biosensors51-53 and bioactuators54,55 logically 
processing complex patterns of biochemical signals, with promise of biomedical 
applications.56-59 
 
Among all Boolean logic operations, XOR (eXcluded OR) gate is the most difficult for 
the chemical realization. This gate should produce 0 output when the inputs are applied at zero 
levels (input combination 0,0). Each input signal applied separately should result in the system 
activation (giving output 1 upon input combinations 0,1 and 1,0). However, simultaneously 
applying both inputs should keep the system inactive (resulting in the output 0 when the inputs 
1,1 are applied). Note that AND logic gates, for instance, respond to two chemical stimuli in a 
natural for chemistry way generating the product only in the presence of both chemicals in the 
system,10,11 while OR gates can be represented by two parallel chemical pathways resulting in 
similar products in the presence of any or both chemical stimuli.12 NAND / NOR logic gates 
represent inversion of the AND / OR functions whereby a certain chemical disappears when the 
gates are active.13-18 INHIB logic gate is also easy for chemistry to mimic since it represents 
inhibition of the product formation in the presence of a certain chemical input, which is also 
rather natural for chemical systems.19-22 However, the XOR function should result in a chemical 
output only in the presence of any one of two inputs applied separately, but the product 
formation should be inhibited in the case of simultaneous presence of both inputs.23-26 This is 
quite unusual for chemical kinetics because two potentially reactive species should cancel each 
other when they both appear in the system.  
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In non-biochemical systems, the XOR function has usually been realized by mutual 
negation of the chemical input signals, e.g., by neutralization of acid and base being used as two 
inputs.23,24 It should be noted that this rather simple way of operation is based on the 
neutralization of the inputs prior to their reaction with the logic gate system. In more 
sophisticated supra-molecular systems input signals resulted in the conversion of a chemical 
complex to another structure (reflected for example by changes in optical absorbance or 
fluorescence) upon binding each chemical input separately at different sites of the complex, 
while binding both of them together resulted in no changes in the optical properties, thus 
mimicking XOR logic gate.25,26 Biomolecular realization of XOR gate can be based on specific 
biorecognition and biocatalytic properties of biochemical systems, using DNA48 and 
enzymes,60-62 respectively. In DNA-based XOR gates single-strand oligonucleotides are used as 
system activating input signals, while their hybridized double-strand derivatives do not activate 
the logic gate.  
 
In enzyme-based logic gates oppositely directed biocatalytic reactions can be activated by 
input signals. Separate application of each chemical input activates one of the reactions resulting 
in the unbalancing of the system and producing the output signal, while simultaneous addition of 
the both inputs would activate both competing reactions, thus keeping a balance in the system 
and producing no chemical output.38,60-62 It should be noted that this kind of XOR gate produces 
oppositely directed chemical changes in the systems (for example increase or decrease in the 
concentration of a certain chemical) upon activation with different input signals. In order to 
fulfill the XOR gate definition, the output signals in these gates were defined as absolute values 
of the concentration changes (or absolute values of the concentration dependent parameters, such 
as optical60-62 or electrochemical output signals38). The latter type of a system is considered in 
this work.  
 
Despite the difficulties in the chemical realization of the XOR logic gate, specific interest 
in it is based on its importance for molecular computing systems where XOR gate is a part of 
basic computing elements: half-adder/half-subtractor63-66 or full-adder/full-subtractor.67,68 These 
basic arithmetic functions were realized using DNA-based69 and enzyme-based70 XOR gates. 
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XOR is also an interesting function for other reasons. It is a part of certain reversible gates 
(CNOT, CCNOT) that have been extensively studied in other unconventional computing 
realizations.71-76 Furthermore, its truth table, given in Scheme 1, suggests that a response-surface 
function of a system that yields XOR at the logic-point inputs 00, 01, 10, 11, may have a saddle 
shape passing through the two output 0s at 00 and 11, but also through the output 1s at 01 and 
10. This makes the study of the noise scaling as a signal is processed by this gate interesting, and 
also suggests more than a single pattern of behavior (different shapes of the "saddle"). Thus, 
various types of XOR gates may have to be considered separately as noise handling components 
of biochemical logic "networks." One such study is carried out in the present work. Generally, 
however, we expect that the XOR gate is more noisy that AND, OR and other gates with less 
"structured" (means, less sloped except at selected points) response surfaces connecting their 
logic points. Therefore, while the study of the noise handling properties upon transmission 
through an XOR gate is interesting, we expect up front that this gate will be a candidate for 
inclusion in networks only provided noise suppressing elements (filters) are utilized, rather than 
directly optimizable for low-noise functioning. 
 
The article is organized as follows. Our experimental system, outlined in Scheme 1, is 
presented in Section 2. Section 3 reports a model suitable for the specific type of XOR 
functioning considered here. Finally, Section 4 presents results, their model analysis, 
optimization, as well as discussion and concluding remarks. 
  
 
2. Experimental: XOR Gate Based on Signal Change 
 
 Chemicals and Materials. Glucose-6-phosphate dehydrogenase (G6PDH) from 
Leuconostoc mesenteroides (E.C. 1.1.1.49), microperoxidase-11 (MP-11) sodium salt ~90% 
(HPLC), D-glucose-6-phosphate sodium salt (G6P), β-nicotinamide adenine dinucleotide sodium 
salt (NAD+) (≥95%), and β-nicotinamide adenine dinucleotide reduced dipotassium salt (NADH) 
were purchased from Sigma-Aldrich and used without further purification. H2O2 (30% w/w) was 
purchased from Fisher. Ultrapure water (18.2 MΩ·cm) from NANOpure Diamond (Barnstead) 
source was used in all of the experiments. 
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 Composition and mapping of the XOR System. The “machinery” of the XOR gate was 
composed of the enzyme: G6PDH (0.1 unit·mL–1) and biocatalyst: MP-11 (8.6 µM) operating 
together with NADH (100 µM) and NAD+ (100 µM) in 50 mM phosphate buffer, pH 7.4. 
Another set of mapping experiments was performed with lower enzyme and biocatalyst 
concentrations: G6PDH (0.05 unit·mL–1), MP-11 (0.86 µM), following optimization suggested 
by modeling reported in Sections 3-4. The enzyme substrate G6P and the biocatalyst oxidizer 
H2O2 were used as the input signals. Logic value 0 for the input signals was defined as the 
absence of G6P and H2O2 in the reacting solution, while their presence at the concentrations of 
1 mM and 50 µM, respectively, was defined as input values 1. In the gate-response mapping 
experiments the input signals were applied at variable concentrations, G6P: 0, 0.25, 0.50, 0.75, 
1.00 and 1.25 mM, and H2O2: 0, 12.5, 25.0, 37.5, 50.0 and 62.5 µM. The response matrix of 36 
experimental points was obtained for these input concentrations. 
 
 Optical Measurements. Absorbance, A, measurements were performed using a 
UV-2401PC/2501PC UV-visible spectrophotometer (Shimadzu, Tokyo, Japan) at (37 ± 0.2) °C. 
The reactions took place in a 1 mL poly(methyl methacrylate), PMMA, cuvette. The change of 
the NADH absorbance was monitored at  = 340 nm.77 A selection of our absorbance data is 
shown in Figure 1. The sampling time, tg, was selected to obtain a well-defined XOR function, 
as detailed in Section 3. The absorbance values were converted to the concentration of NADH 
using its molar extinction coefficient, ε340 = 6.22·103 M–1·cm–1.77 The XOR output signal was 
defined as the absolute value of the change in the NADH concentration during the gate function. 
Since some other chemicals, most notably MP-11 and NAD+, can contribute, to a limited extent, 
to the absorbance at  = 340 nm, we used the change in the absorbance as compared to that at 
time 0 for input (0,0) to estimate the difference Δ[NADH](tg) = [NADH](tg) – [NADH](0), rather 
than directly subtracting the actual [NADH](0) value. 
 
 Parameter Selection for the XOR Gate. Generally, the system of biocatalytic reactions 
shown in Scheme 1, will not yield the XOR binary function unless the experimental parameters 
are properly selected. Here we consider the initial-time, 0t  , concentration [G6P](0) as Input 1, 
with the reference binary logic values 0 and [G6P]max. Similarly, [H2O2](0) is Input 2, with the 
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logic values 0 and [H2O2]max. The XOR output, |Δ[NADH](tg)|, is calculated from the change in 
the absorbance, as the absolute value of the difference Δ[NADH](tg) at a certain "gate time," 
g 0t  , with respect to the initial value at 0t   for input (0,0), as mentioned above. The inputs 
are in principle determined by the utilization of the gate in specific applications, whereas the 
logic-0 and 1 values of the output, here assumed 0 and |Δ[NADH]|max, are largely set by the gate-
function itself (up to uncertainty due to intrinsic noise). However, the relative "activities" of the 
two branches of the reaction must be adjusted to yield the XOR function, depending on the 
initial ratio of [NADH](0)/[NAD+](0). This point will be explained by the model of the next 
section, as will be our choice of this ratio at value 1.  
 
 Furthermore, the quality of the XOR function depends on the choice of the gate time, gt . 
The choice of gt  will also be to a certain extent explained by the model in Section 3, which is, 
however, a simplified phenomenological description of the biocatalytic kinetics. The gate times 
marked by the vertical lines in Figure 1, were selected to have both logic-0 output values 
approximately equal to 0, and for both logic-1 outputs — approximately equal to each other 
absolute values of the deviation from 0. However, we also sought gate times for which the 
outputs for input pairs multiplied by equal factors (additional data also shown in the figure), are 
close to 0. This will be explained in the next section. The choice of the gate times is not unique, 
and the quality of the approximation of the XOR by the output signals is not ideal, see Figure 2, 
but it definitely compares favorably to a typical such built-in "intrinsic-noise" spread/shift of 
logic-point values for gates reported in the chemical and biochemical computing literature. The 
actual values for our choice of g 150 sect   and 215 sec for the two experiments shown in the 
top and bottom panels of Figure 1, respectively, are shown as bar charts in Figure 2. 
 
 
3. Model of the XOR Response Surface 
  
 As described in the preceding section, in order to explore the noise scaling properties78-81 
of the realized XOR gate we map out the output of the biocatalytic processes at input values 
other than the logic 0s and 1s. Specifically, we define the rescaled logic-range variables 
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x = [G6P](0) /[G6P]max , 
 
y = [H2O2](0) / [H2O2]max , 
 
z = |Δ[NADH](tg)| / |Δ[NADH]|max , 
(1) 
 
in terms of which the gate-response function ( , )z x y  can be considered, with 0 , , 1x y z  . Our 
experiments provide a mapping of this function for 36 combinations , 0, ..., 1.25x y  , within and 
somewhat beyond the "logic" range. The behavior of the function ( , )z x y  near the logic points 
( , ) (0,0),(0,1),(1,0), (1,1)x y   determines78 the degree to which the gate amplifies or suppresses 
analog noise in the inputs. There are other sources of noise in biomolecular gates and in their 
networks with other gates and non-binary elements. For example, the deviations of the output 
from the selected logic-0 or 1 binary values, see Figure 2, are part of the "intrinsic" noise in the 
values of the function ( , )z x y  itself, which ideally should be exactly at z = 0, 1, 1, 0 for xy = 00, 
01, 10, 11 input combinations, respectively. 
 
 Most biochemical gates studied for their analog-noise amplification properties, have a 
smooth, convex function ( , )z x y . The noise-spread scaling factor upon noisy signals passing 
through the gate, can then be estimated simply as the slope, | ( , ) |z x y  at each of the four logic 
points. The largest of the slopes has typically been found larger than 1 for convex AND gate 
response surfaces studied.78 Therefore, such gates typically amplify noise, by a significant factor, 
e.g., 300–500%. However, the gate-response function ( , ;...)z x y , in addition to the scaled inputs 
x and y, also depends parametrically on other variables, here shown as …, such as the initial 
concentrations of the biocatalysts and other chemicals that can be adjusted. For AND gates the 
experience has been27,78 that noise amplification can be reduced to approximately 120% (factor 
~ 1.2). However, this direct gate optimization is difficult because large changes in the 
controllable concentrations and other parameters are needed. Other approaches have been tried, 
such as non-smooth surfaces and partially sigmoidal ones. These have been limited to specific 
examples, 27,80,81 and the present understanding seems to be that, only network-level optimization 
(filtering, etc.) with the help of additional network elements, can fully control analog noise 
proliferation for useful applications of complex biochemical logic circuitry. Ultimately, for 
– 8 – 
 
larger networks, of more than about 10 gates, digital error correction by redundancy will also be 
required. 78,81 
 
 Here we aim at a study of the noise scaling properties of the realized XOR gate. In order 
to develop a model for the function ( , ;...)z x y , we could attempt a detailed kinetic description of 
the processes biocatalyzed by G6PDH and MP-11, see Scheme 1. The mechanisms of action of 
both biocatalysts, especially G6PDH, is, however, rather complicated,82-84 involving several 
complex pathways and a possible allostericity.80,85 Detailed modeling would require introduction 
of several rate constants, most of which are not known from the literature, and is not practical 
based only on the available data for the present XOR gate realization. The other extreme has 
been to rely on purely phenomenological fitting forms79,86 for ( , ;...)z x y . The latter approach, 
tested for AND gates, including a small network,86 introduces a couple of ad-hoc parameters — 
those denoted by … in our notation for ( , ;...)z x y  — which can be fitted from the data, but their 
relation to the adjustable physical or chemical conditions of the experiment is not 
straightforward.  
 
 Here we adapt an intermediate approach. Due to complexity of the actual kinetics we do 
not attempt detailed modeling. However, we do retain a more direct relation of the rate 
parameters introduced to the actual processes involved, which is useful for gate-functioning 
optimization, as will be illustrated in this and the next section. Specifically, we consider the two 
branches of the XOR scheme, converting the two "competing" chemicals: NADH, of 
concentration of be denoted ( ) [NADH]( )P t t , and NAD+, of concentration +( ) [NAD ]( )S t t , 
into one another: 
 
( ) ( )S t P t


 , (2) 
 
where the rate constants, ,  , will be the two phenomenological quantities that represent the 
overall activity of the respectively G6PDH and MP-11 branches of the processes depicted in 
Scheme 1. Specifically, we expect that   is roughly proportional to the initial concentrations of 
Input 1, [G6P](0), and the enzyme, [G6PDH](0), whereas   is similarly related to Input 2, 
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[H2O2](0), and the biocatalyst, [MP-11](0). This is obviously a rather crude model, because it 
lumps complicated kinetics into only a single parameter for each branch. Furthermore, even if 
the model is taken at face value, conclusions such as the approximate proportionalities just 
mentioned, can be questioned. We already mentioned a possible allostericity80,85 of G6PDH, 
implying nonlinear dependence on its substrate concentration(s). For the other branch, hydrogen 
peroxide can in fact inhibit MP-11, though we are working well below the relevant 
concentrations.87,88 
 
 Despite its obvious gross limitations as a realistic model of the biocatalytic processes 
involved, the present approach has advantages that make it practical for our purposes. It limits 
the number of fit parameters to reasonable (just two) for the quality of the available data. In 
addition, we note that we are only interested in a rather approximate description of the whole 
response surface, which will capture its general shape features and specifically the slope values 
near the four logic points and their relative variation as functions of the adjustable quantities. 
Finally, the present model provides a direct prescription for varying the introduced parameters 
,  , by adjusting the main controlled quantities of the gate function: the initial biocatalyst 
concentrations. We expect that variation of the latter will roughly translate into proportional 
variation of the respective rate constants. 
 
 The rate equations corresponding to Eq. (2) are easy to formulate and solve: 
 
( ) ( ) ( ) ( )dP t dS t S t P t
dt dt
     , 
 
g( )
g
(0) (0)( ) (0) [1 ]tS PP t P e    
    , 
(3) 
 
where the result is here written in the form the absolute value of which is our XOR signal at tg. 
We note that, since the parameters ,   are assumed proportional to the inputs, then their values 
at the logic-1 inputs ([G6P]max, [H2O2]max) can be identified: max max,  . Eq. (1) then suggest 
that max/x    and max/y   . The calculation of z in this notation will be addressed later. It 
is important to emphasize that while Eq. (3) gives signal 0 at inputs (0,0), it should also give 
output 0 at inputs max max( , )  . Otherwise, we will not have the XOR function. Furthermore, 
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the positive output signal at inputs max( , 0)  and the negative signal obtained at max(0, ) , 
should have magnitudes equal to one another, because otherwise the gate will not mimic the 
binary XOR after taking the absolute value for the final signal definition. This suggests that the 
parameters of the model are not arbitrary but must satisfy the following relations: 
 
max g
max g
max
max
(0) 1
(0) 1
t
t
S e
P e






 

. (4) 
 
If our model is taken literally as the precise description of the biocatalytic processes involved in 
the gate dynamics, then Eq. (4) imply that for an arbitrary choice of the gate time tg, we have to 
adjust the activities (balance the amounts of the biocatalysts) in the two branches, and also adjust 
the initial quantities of the two chemicals that are being interconverted into one another, to have 
 
max max     and   (0) (0)S P . (5) 
 
 
 In reality, of course, the present model is approximate and therefore, these requirements 
are not fully accurate. Indeed, we selected equal initial values of the concentrations P(0) = 
[NADH](0) and S(0) = [NAD+](0) to have a well-approximated XOR function. However, the 
relation between the variables max , max  and tg is in reality likely more complicated than 
predicted in Eq. (5). Indeed, the (1,1) data in particular, in Figure 1, shows the time dependence 
which is obviously not monotonic, as predicted by relations of the type of Eq. (3). Therefore, the 
model predictions, and the degree to which the XOR function can be reproduced by the present 
system, are both limited. In fact, our specific values of tg selected, marked in Figure 1, are those 
for which a compromise is reached in the degree to which the system approximates all the 
aforementioned XOR requirements. Furthermore, the form of Eq. (3) suggests that the signal 
should actually vanish for this type of XOR also when the inputs are equal fractions of the 
maximum values: max max/ /    . Indeed, as seen in Figure 1, the data sets for such 
fractional inputs approximately all intersect close to zero signal in the vicinity of the selected tg. 
Thus, the reference gate times selected, were those that approximately yield output 0 for several 
equal inputs, varying from both inputs being zero to both inputs assuming values 1 and beyond. 
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Furthermore, the inputs 01 and 10 were expected to yield approximately equal in absolute value 
signals based on the absorbance change, at tg. 
 
 With these reservations in mind both with regards to the precision of the model and to the 
accuracy with which the selected system actually yields XOR, we can utilize the present model 
for a semi-quantitative data fit to attempt to optimize the initial, randomly selected (for 
experimental convenience) parameter values (specifically, the biocatalyst concentrations which 
control the "activity" of the two branches). This optimization, carried out in Section 4, yielded 
the second set of experiments reported in Figures 1 and 2. 
  
 Within the framework of the model, if all the conditions are exactly satisfied, we can now 
divide the absolute value of the difference signal in Eq. (3), by the maximal signal, and introduce 
the rescaled variables, to get the final expression for the gate-response function, 
 
( )| | 1( , )
1
a x y
a
x y ez x y
x y e
 

    ,   where   max g max g( )a t t   . (6) 
 
Thus, within the present model the XOR gate response surface depends on a single 
dimensionless parameter, 0a  . Note that as 0a  , we have ( , ) | |z x y x y  . Figure 3 shows 
the function in Eq. (6) for illustrative values 4a   and ¼. The function is smooth except for the 
crease at z = 0, along the diagonal x = y. The latter is due to taking the absolute value, and we 
know from other studies79 (for an AND gate) that such a line of non-smooth behavior does not 
invalidate the property that, for narrow enough noise distribution in the inputs, the slope of the 
function (without the |…|) in Eq. (6) gives a good measure of the noise amplification factor as 
the signal is converted into the output. These slopes are plotted in Figure 4. 
 
 Figure 4 indicates that the largest slope is always greater than approximately 1.4, which 
means that XOR gates of this type always amplify analog noise by adding at least 40% to the 
relative width of the signal distribution. We note that a similar estimate for AND gates was close 
to 20%,78 which confirms our expectation that XORs — gates with two diagonally positioned 
outputs 0 and two outputs 1 — are generally noisier than gates with only a single output value 
different from the other three outputs. Figures 3 and 4 indicate that the optimal shape for reduced 
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analog noise amplification for this type of XOR gates — those with the "saddle pass" depressed 
low towards the xy plane (in our case, the extreme: touching the xy plane as the diagonal crease) 
— is made of two flat triangles, obtained in the limit of small a. This, however, brings out 
another problem: such linear response surfaces are usually obtained when the concentrations of 
most of the reactants are generally made small (to decrease the activities of all the reaction 
pathways) or the gate time is very small. Then the separation between the physical values for 
logic-0 and 1 outputs will also be reduced, resulting in another source of noise: The intrinsic 
noise due to inaccuracies in the gate realization and fluctuations in the response function itself 
might become large on the relative scale (i.e., it will be difficult to distinguish between the logic-
0 and 1 signals). Thus, XOR gate optimization is generally more challenging than that for AND 
gates. 
 
 
4. Analysis of the Experimental Data, and Discussion 
  
 Our first set of the reaction parameters was selected based primarily on the experimental 
convenience. We did satisfy one of the model requirements: [NAD+](0) = [NADH](0), which are 
expected to lead to better conformity of the resulting output values with the XOR function. 
However, the second requirement, that of making the "activities" of the two biocatalytic branches 
approximately equal, max max  , is less straightforward not only because the proportionality 
constants relating these quantities to concentration are not known, but also because the 
applicability of our phenomenological model itself is at best semi-quantitative. We will return to 
this condition shortly. 
 
 In order to cast our data, e.g., Figure 1, at tg in terms of the "logic" value ranges, we kept 
the choice of the physical 0 as the logic-0, despite the fact that the actual gate realizations give 
small positive outputs (Figure 2). For logic-1, we took the arithmetic means of the two positive 
values obtained at the appropriate logic points, 01 and 10 (Figure 2). Our original data set at tg, is 
displayed in Figure 5. The data were fitted by the form suggested by Eq. (6). The estimate for the 
adjustable parameter was a = 1.06. This suggests that the original gate is rather noisy: at this 
value of a, the noise amplification factor is 229% (this is outside the range of Figure 4), i.e., the 
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noise level is more than doubled due to the gate function. Furthermore, the quality of the root-
mean-squares fit of the data is not that great. This is an indirect indication that the model is not 
describing the data well. Indeed, consideration of the time-dependence of the (0,1) vs. (1,0) 
curves in the top panel of Figure 1, suggests that the MP-11 branch of the reaction is much more 
"active" (faster onset of saturation) than the G6PDH branch, i.e., that the original parameter 
selection was quite far from satisfying the requirement max max   for a quality XOR 
functioning. 
 
 The above considerations suggest that an improved set of parameters should be selected 
whereby the activities of both branches of the process are lowered, but the one for MP-11 should 
be reduced by a significantly larger factor. Indeed, our modified experiment, for which the 
"logic" data and its model fit are shown in Figure 6, had the initial concentration of G6PDH 
reduced by a factor of 2, whereas that of MP-11 reduced by a factor of 10. While the resulting 
XOR function is still not fully symmetric (Figure 2), the time scales of the variation of the (0,1) 
vs. (1,0) curves in the bottom panel of Figure 1, are more comparable, which suggests that the 
condition max max   is closer satisfied. Furthermore, the fitted value, a = 0.459, now 
corresponds to the noise amplification factor of 176%, which is a significant improvement. Note 
that the optimal value for this type of XOR gate is approximately 140%, but to achieve it, the 
activity of the reaction branches would have to be reduced too much, resulting in very small 
signals. Indeed, our optimization already reduced the output signal strength by approximately a 
factor of 2, as can be seen in Figure 2. 
  
 In summary, we developed an approach to analyze and optimize the noise-scaling 
properties of XOR gates of the "signal change" type.38,60-62 Our general conclusions are that, 
such gates are actually somewhat noisier and more difficult to optimize than earlier studied AND 
gates. We emphasize that, as described in the Introduction, other types of XOR gate are possible, 
and their noise-handling properties should be studied in the future. For the presently considered 
gates, the smallest possible noise amplification factors of ~ 1.4 are difficult to achieve, because 
the regime required is that of weak output signals. However, we demonstrated experimentally 
that factors ~ 1.8 are feasible with reasonable degree of modeling-enabled optimization of the 
gate-parameter choices. 
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Scheme 1. Schematic of the biocatalytic processes utilized in the XOR gate functioning. (The 
abbreviations for the chemicals are defined in the text.) Top Inset: The truth table of the XOR 
gate. 
Input1 = [G6P]
G6P NAD+ H2O2
Input 2 = [H2O2]
G6PDH MP?11
NADH
Output = [NADH]
Input 1 Input 2 XOR Output
0 0 0 
0 1 1 
1 0 1 
1 1 0 
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Figure 1. The four heavy-symbol lines show the time-dependent data obtained with inputs at the 
selected referenced logic-0 or 1 values (four possible combinations). The top panel corresponds 
to the original biocatalyst concentrations, whereas the bottom panel gives data for the optimized-
gate case (with reduced noise amplification), as detailed in Section 4. Out of the total 36 data sets 
obtained by varying the inputs independently in ratios 0, 1/4, 1/2, 3/4 1, 5/4 of the logic-1 values, 
we show, in addition to the 4 combinations (0,0), (0,1), (1,0), (1,1), also the curves obtained for 
inputs at (1/4,1/4), (1/2,1/2), (3/4,3/4), (5/4,5/4) of the logic-1 inputs. These data are useful in 
explaining the selections of the sampling (gate) times (see text), marked by dotted vertical lines. 
The four additional time-dependent data sets are plotted with less-heavy, black symbols, and 
their fixed-time values are monotonically decreasing at times close to 50 sec in the top panel; 
monotonically increasing at times close to 300 sec in the bottom panel. 
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Figure 2. Bar charts illustrating the degree of accuracy to which the XOR function is realized in 
the present system. The signals were obtained from the absorbance (Figure 1) data at the selected 
tg values, as the absolute values of the concentration differences — with respect to the t = 0 logic 
input (0,0) reference — for NADH. The signs of the concentration differences before taking the 
absolute value are also shown. The values are color-coded to the data in Figure 1, and the top 
panel corresponds to the original biocatalyst concentrations (as in Figure 1), whereas the bottom 
panel corresponds to the modified experiment. The dashed horizontal lines show the selected 
logic-1 values, as explained in the text: 0.069 mM and 0.029 mM, for the original and modified 
experiments, respectively. 
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Figure 3. The shape of the model response function for our XOR gate, with a = 4 (top panel) 
and ¼ (bottom panel). Note that the origin of the three-dimensional coordinate system is in the 
lower-right corner of the unit cube in this view. 
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Figure 4. Variation of the slopes of the gate-response function in Eq. (6) with the parameter a. 
The curves give the magnitudes of the gradients at the four logic points, as marked in the plot. 
For x = y, the gradients were calculated before taking the absolute value in Eq. (6). 
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Figure 5. Top panel: Experimental data scaled by the "logic-1" output value, for the original data 
set. Bottom panel: Model fit of the data, yielding a = 1.06. Note that both the data and the fitting 
function, Eq. (6), here extend beyond the logic-1 values. 
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Figure 6. Same as Figure 5, but for the "optimized experiment" data set, with the fitted value a = 
0.459. 
 
 
